The Proteasome Inhibitor Velcade Enhances rather than Reduces Disease in Mouse Hepatitis Coronavirus-Infected Mice
- 1 August 2010
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 84 (15), 7880-7885
- https://doi.org/10.1128/jvi.00486-10
Abstract
Many viruses, including coronaviruses (CoVs), depend on a functional cellular proteasome for efficient infectionin vitro. Hence, the proteasome inhibitor Velcade (bortezomib), a clinically approved anticancer drug, shown in an accompanying study (M. Raaben et al., J. Virol. 84:7869-7879, 2010) to strongly inhibit mouse hepatitis CoV (MHV) infection in cultured cells, seemed an attractive candidate for testing its antiviral propertiesin vivo. Surprisingly, however, the drug did not reduce replication of the virus in mice. Rather, inhibition of the proteasome caused enhanced infection with lethal outcome, calling for caution when using this type of drug during infection.Keywords
This publication has 52 references indexed in Scilit:
- The Ubiquitin-Proteasome System Plays an Important Role during Various Stages of the Coronavirus Infection CycleJournal of Virology, 2010
- Type I interferon receptor-independent and -dependent host transcriptional responses to mouse hepatitis coronavirus infection in vivoBMC Genomics, 2009
- Inhibition of the Ubiquitin-Proteasome System Prevents Vaccinia Virus DNA Replication and Expression of Intermediate and Late GenesJournal of Virology, 2009
- Orthopoxviruses Require a Functional Ubiquitin-Proteasome System for Productive ReplicationJournal of Virology, 2009
- Vorinostat and bortezomib exert synergistic antiproliferative and proapoptotic effects in colon cancer cell modelsMolecular Cancer Therapeutics, 2009
- Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Improved microarray gene expression profiling of virus-infected cells after removal of viral RNABMC Genomics, 2008
- Proteasome inhibition suppresses essential immune functions of human CD4+ T cellsImmunology, 2008
- Bortezomib Induces Apoptosis of Epstein-Barr Virus (EBV)-Transformed B Cells and Prolongs Survival of Mice Inoculated with EBV-Transformed B CellsJournal of Virology, 2007
- Structure of 20S proteasome from yeast at 2.4Å resolutionNature, 1997